At A Glance:

Opioid-induced constipation (OIC) is projected to hit $2.8 billion by 2022, according to Credence Research (March 2016 report). Growth for this market will come from the introduction of several new drugs, including this sponsor’s compound, which would be the first to market in a new class.

Download PDF

Opioid-Induced Constipation

Site enrollment rate increase: 77%
Cost savings: $13.9 million
(vs. adding sites)
See the results